OnDemand Retina Update Featuring The 14th Annual J. Arch McNamara, MD Memorial Lecture


OnDemand Retina Update Featuring The 14th Annual J. Arch McNamara, MD Memorial Lecture Banner



Date & Location
Monday, December 16, 2024, 8:00 AM - Tuesday, December 16, 2025, 12:00 PM

Registration
Registration for this event is free.

Target Audience
Specialties - Retina and Vitreous

Credits
AMA PRA Category 1 Credits™ (4.00 hours), Non-Physician Attendance (4.00 hours)

Overview

With the emergence of new technologies, treatments, and clinical trial results, ophthalmologists need to understand how to incorporate these advances into clinical care. We will discuss latest advances in the management of inherited and acquired ophthalmic diseases and evidence for emerging therapies and screening modalities. Both didactic and case-based educational formats will be utilized to illustrate current trends in the management of complex and routine ophthalmic patients, taking into account diagnostics as well as nonsurgical and surgical treatment.

This conference will focus on the latest advances in the management of complex medical and surgical retina cases. Both didactic and case-based educational formats will be used to highlight current trends in the management of these complex cases. There will also be a focus on complex cases in the various subspecialties of vitreoretinal disease including pediatrics, uveitis, and inherited retinal diseases.

Aaron Nagiel, MD, PhD is an Assistant Professor of Ophthalmology at Children’s Hospital Los Angeles, affiliated with the USC Roski Eye Institute/Keck School of Medicine in Los Angeles, California. As a surgeon specializing in retinal disorders of childhood and adolescence, he complements this clinical expertise with an active laboratory and translational research program. This includes the establishment of a nationally recognized retinal gene therapy program that has performed dozens of gene therapy surgeries, including for clinical trials.

Dr. Nagiel earned his bachelor’s degree from Harvard University summa cum laude, and then underwent combined MD and PhD training at Cornell University and The Rockefeller University in New York City. After an internship at Memorial Sloan-Kettering Cancer Center, Dr. Nagiel completed both ophthalmology residency and vitreoretinal fellowship at the Stein Eye Institute at UCLA.

Dr. Nagiel is a recipient of numerous grants and awards including the Heed Ophthalmic Foundation Fellowship, the Ronald G. Michels Fellowship Foundation Award, Knights Templar Eye Foundation Career Development Award, a National Eye Institute Clinical Scientist Training Grant (K08), and a Research to Prevent Blindness Career Development Award.


Objectives
At the conclusion of this activity, learners will be able to:

  1. Speak with patients about the evolving landscape of IRDs and treatments.
  2. Collaborate with peers in preparation for gene therapy interventions and genomic analyses.
  3. Understand the current advances in the management of proliferative vitreoretinopathy
  4. Coordinate management and treatment plans for patients with dislocated intraocular lenses.

Accreditation
Wills Eye Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Statement
Wills Eye Hospital designates this Enduring Material for a maximum of 4.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.